A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form.
The research was published ahead of print in Antimicrobial Agents and Chemotherapy.
Chagas disease or American trypanosomiasis, caused by Trypanosoma cruzi, affects about 18 million people living mostly in Latin America. The parasite is transmitted to humans by blood-sucking reduviid bugs, also known as kissing bugs due to their predilection for feeding on the faces of their victims. In the United States, Chagas disease is considered one of the neglected parasitic infections, a group of five parasitic diseases that have been targeted by CDC for public health action.
“While historically infection was largely confined to poor and rural populations in Central and South America, it has been emerging in the U.S., Canada, Europe, Japan, and Australia, due to immigration, and nonvectorial transmission is becoming a public health threat,” says Deborah Nicoll-Griffith of the Merck Frosst Centre for Therapeutic Research in Kirkland, Quebec, a researcher on the study. One 2005 estimate put the number of people infected within the U.S. at 300,000 (1/1000).
There are two phases of Chagas disease: the acute phase and the chronic phase. Both phases can be symptom free or life threatening. Left untreated the disease can lead to cardiac and digestive disorders, as the parasite burrows into the heart, esophagus and colon tissue where it causes damage over time.
The current standard of care, the drug benznidazole, has significant activity against the parasite during the acute phase, but is less effective once the disease becomes chronic.
Efforts to find new drugs focus on disrupting an enzyme, cruzipain, which the parasite uses for digestion, to produce other cellular machinery, to evade the host’s immune system, and to invade heart and gastrointestinal tissues.
Nicoll-Griffith and her colleagues identified two compounds known as reversible cysteine protease inhibitors that fit cruzipain like jigsaw puzzle pieces, jamming the enzyme. In the study, they tested the efficacy of the compounds in mice against that of benznidazole. While all treatment groups showed a marked reduction in parasite burden, in all tissues, the two experimental compounds had greater cure rates of acute infections (90% and 78%) compared to benznidazole (71%.)
The Latest on: Chagas Disease
via Google News
The Latest on: Chagas Disease
- Marking World Neglected Tropical Diseases Dayon January 18, 2021 at 4:00 pm
By Sharon AtienoIn gearing up for this year’s Neglected Tropical Diseases Day, on 30th January, the World Health Organization (WHO) is set to launch a new roadmap for the next decade.Ending the ...
- Marking World Neglected Tropical Disease Dayon January 18, 2021 at 4:00 pm
By Sharon AtienoIn gearing up for this year’s Neglected Tropical Disease Day, on 30th January, the World Health Organization (WHO) is set to launch a new roadmap for the next decade.Ending the neglect ...
- Face-biting 'kissing bugs' are spreading a serious potentially fatal diseaseon January 12, 2021 at 3:59 pm
725 S. Floyd Street Louisville, KY 40203 (502) 585-2201 ...
- Strongyloidiasis News and Researchon January 10, 2021 at 4:00 pm
Chagas Disease (caused by the parasite Trypanosoma cruzi) and strongyloidiasis (caused by the helminth S. stercoralis) are neglected tropical diseases that share a similar epidemiological burden ...
- Accelerating the Development of a Therapeutic Vaccine for Human Chagas Diseaseon January 10, 2021 at 4:00 pm
The advantages of a therapeutic Chagas disease vaccine compared with benznidazole alone (the current major competing product in clinical use) could include the following: Three recent ...
- Chagas Disease, Franceon January 2, 2021 at 4:00 pm
Chagas disease (CD) is endemic to Latin America; its prevalence is highest in Bolivia. CD is sometimes seen in the United States and Canada among migrants from Latin America, whereas it is rare in ...
- Chagas Diseaseon December 20, 2020 at 4:01 pm
A new study examines local perceptions of Chagas disease in a region where the infectious agent is endemic. The results underline the need to take social and cultural factors into account in ...
- A blood-sucking, face-biting bug is spreading through the USon December 18, 2020 at 11:58 am
While kissing bug bites aren't dangerous, the insect can transmit a parasite that causes a serious but treatable condition called Chagas disease. In July 2018, a Delaware family in Kent County ...
- Metabolic State of a Parasite Influences Its Resistance to Drugson December 2, 2020 at 2:50 am
The study in cultures of human cells infected with Trypanosoma cruzi (T. cruzi), the parasite that causes Chagas disease, suggests that its metabolic state influences the effectiveness of azole drugs ...
- Chagas' Diseaseon October 12, 2020 at 10:36 pm
Chagas' disease continues to be among the most important diseases in the tropics and subtropics of North and South America. According to the World Health Organization, 25% of the total population in ...
via Bing News